Utidelone monotherapy suggesting clinical efficacy in heavily pretreated platinum-resistant high-grade serous ovarian cancer: a case report
Abstract Background Platinum-resistant ovarian cancer (OC) presents a significant therapeutic challenge with limited effective salvage options and dismal survival outcomes. Utidelone (UTD1), a novel synthetic epothilone B analogue that circumvents P-glycoprotein-mediated drug efflux, demonstrates pr...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
SpringerOpen
2026-04-01
|
| Sraith: | Bulletin of the National Research Centre |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1186/s42269-026-01433-8 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|